Arteris (NASDAQ:AIP) CEO Sells $230,605.76 in Stock

Arteris, Inc. (NASDAQ:AIP) CEO K Janac sold 9,359 shares of Arteris stock in a transaction on Friday, October 2nd. The shares were sold at an average price of $24.64, for a total value of $230,605.76. Following the sale, the chief executive officer directly owned 165,789 shares of the company’s stock, valued at approximately $4,085,040.96. The trade was a 5.34% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

K Charles Janac also recently made the following trade(s):

• On Monday, October 5th, K Janac sold 11,452 shares of Arteris stock. The shares were sold at an average price of $24.27, for a total value of $277,940.04.
• On Thursday, October 1st, K Janac sold 100,000 shares of Arteris stock. The stock was sold at an average price of $23.82, for a total value of $2,382,000.00.
• On Tuesday, September 1st, K Janac sold 100,000 shares of Arteris stock. The stock was sold at an average price of $20.75, for a total value of $2,075,000.00.
• On Tuesday, August 4th, K Janac sold 26,106 shares of Arteris stock. The shares were sold at an average price of $31.97, for a total transaction of $834,608.82.
• On Monday, August 3rd, K Janac sold 73,894 shares of Arteris stock. The shares were sold at an average price of $30.00, for a total transaction of $2,216,820.00.

Arteris Stock Performance

AIP stock opened at $23.40 on Thursday. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.03. The company has a market capitalization of $1.15 billion, a price-to-earnings ratio of -26.90 and a beta of 1.90. Arteris, Inc. has a 12 month low of $12.06 and a 12 month high of $50.26. The firm has a 50 day moving average of $24.57 and a two-hundred day moving average of $28.72.

Arteris (NASDAQ:AIP) last announced its quarterly earnings results on Thursday, August 6th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.06). The business had revenue of $24.13 million for the quarter, compared to analyst estimates of $23.48 million. Arteris had a negative return on equity of 295.96% and a negative net margin of 46.70%. As a group, equities analysts anticipate that Arteris, Inc. will post -0.68 EPS for the current fiscal year.

Arteris News Roundup

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris secured an additional $3.3 million through the Trusted and Assured Microelectronics program to expand its third-party semiconductor IP security-assurance initiative with BAE Systems and SiFive. The program could strengthen Arteris’ position in secure chip design, government projects and advanced semiconductor supply chains. Arteris funding announcement
• Positive Sentiment: Oppenheimer maintained its Buy rating on Arteris, providing continued support from Wall Street despite recent selling pressure. Oppenheimer rating report
• Neutral Sentiment: CEO K. Charles Janac, COO Laurent Moll and VP Paul Alpern reported multiple sales of vested shares. Several transactions were made to cover tax-withholding obligations, making them a weaker signal of declining management confidence; however, the repeated executive selling may still weigh on short-term sentiment. Arteris insider trading report
• Negative Sentiment: Bayview Legacy LLC sold 100,000 shares for roughly $2.38 million. Because the filing did not identify tax withholding as the reason, the sale may raise concerns about additional stock supply and investor conviction. Bayview Legacy share sale
• Negative Sentiment: Arteris’ latest reported quarter included an adjusted loss of $0.10 per share, worse than the expected $0.04 loss. Although revenue exceeded forecasts, the company remains loss-making, with analysts expecting a full-year loss.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in AIP. BlackRock Inc. acquired a new position in shares of Arteris during the second quarter worth approximately $160,129,000. Needham Investment Management LLC grew its stake in shares of Arteris by 2.6% in the fourth quarter. Needham Investment Management LLC now owns 3,411,500 shares of the company’s stock worth $52,878,000 after acquiring an additional 86,500 shares during the last quarter. Wellington Management Group LLP increased its position in Arteris by 0.4% during the second quarter. Wellington Management Group LLP now owns 500,200 shares of the company’s stock worth $24,305,000 after acquiring an additional 1,897 shares during the period. Granahan Investment Management LLC raised its stake in Arteris by 201.0% during the 1st quarter. Granahan Investment Management LLC now owns 713,077 shares of the company’s stock valued at $11,723,000 after purchasing an additional 476,181 shares during the last quarter. Finally, Algert Global LLC bought a new stake in Arteris in the 2nd quarter valued at $11,602,000. 64.36% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have weighed in on AIP. Roth Capital initiated coverage on Arteris in a research report on Tuesday, August 4th. They issued a “buy” rating and a $40.00 price target for the company. Jefferies Financial Group raised Arteris from a “hold” rating to a “buy” rating and increased their price objective for the company from $35.00 to $50.00 in a report on Friday, August 7th. Rosenblatt Securities restated a “buy” rating and issued a $38.00 target price on shares of Arteris in a report on Friday, August 7th. Craig Hallum started coverage on Arteris in a research report on Monday, September 21st. They set a “buy” rating and a $30.00 target price for the company. Finally, Weiss Ratings upgraded Arteris from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, August 21st. Six investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $39.43.

About Arteris

Arteris, Inc is a semiconductor intellectual property (IP) company that develops technologies used in the design of system-on-chip (SoC) devices. Its products help semiconductor and electronics companies connect, manage and protect the various processing, memory and other functional components integrated into complex chips.

The company’s portfolio includes network-on-chip (NoC) interconnect IP, which supports communication among different elements within an SoC, as well as cache-coherent interconnect, system IP and related design technologies.